Review article · 2025 · Open access
Antimicrobial use and resistance
BMJ, 391, e082681 · Published 12 December 2025 · DOI 10.1136/bmj-2024-082681
In brief
“Antimicrobial use and resistance” is a 2025 review article by Nada Reza and 3 co-authors, published in BMJ. OpenAlex counts 48 citations as of 17 November 2026, which puts it in the top 1% of works published in 2025 by citations. It is open access: the full text is free to read at BMJ.
- Citations
- 48
- Most cited in
- 2026 (48)
- Field-weighted impact
- 5.28
- References
- 173
- Authors
- 4
Abstract
Antimicrobial resistance affects the delivery of safe and effective healthcare. Antimicrobial resistance has attracted strong political focus, with the 2024 United Nations General Assembly high level meeting providing a clear commitment to reducing mortality and improving antibiotic use. This review summarises recent political action, policy prioritisation, and identification of future threats. It considers infections that are caused by drug resistant pathogens and reviews available and new antibiotics that may meet unmet medical needs. Despite increasing political engagement, the global antimicrobial resistance landscape remains imbalanced. In high income hospital settings, diagnostics, antimicrobial stewardship, and infection prevention and control are improving and may be further enabled by artificial intelligence and information systems. The development and use of new antibiotics is a major focus. By contrast, in low and middle income countries, access to most of these advances is limited. In all settings, empirical prescribing of essential antibiotics remains the cornerstone of treatment and conserving their efficacy is critical to effective healthcare. Targeted prevention and optimal treatment strategies are needed to mitigate antimicrobial resistance across all settings.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Reza, N., Dubey, V., Sharland, M., & Hope, W. W. (2025). Antimicrobial use and resistance. BMJ, 391, e082681. https://doi.org/10.1136/bmj-2024-082681
MLA 9
Reza, Nada, et al. “Antimicrobial use and resistance.” BMJ, vol. 391, 2025, p. e082681. https://doi.org/10.1136/bmj-2024-082681.
Chicago
Reza, Nada, Vineet Dubey, Mike Sharland, and William W. Hope. 2025. “Antimicrobial use and resistance.” BMJ 391: e082681. https://doi.org/10.1136/bmj-2024-082681.
Harvard
Reza, N. et al. (2025) ‘Antimicrobial use and resistance’, BMJ, 391, p. e082681. doi:10.1136/bmj-2024-082681.
IEEE
N. Reza, V. Dubey, M. Sharland, and W. W. Hope, “Antimicrobial use and resistance,” BMJ, vol. 391, p. e082681, 2025, doi: 10.1136/bmj-2024-082681.
BibTeX
@article{reza2025antimicrobial,
title = {{Antimicrobial use and resistance}},
author = {Reza, Nada and Dubey, Vineet and Sharland, Mike and Hope, William W.},
journal = {BMJ},
year = {2025},
volume = {391},
pages = {e082681},
doi = {10.1136/bmj-2024-082681},
url = {https://doi.org/10.1136/bmj-2024-082681}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- antimicrobial resistance
- antimicrobial use
- antibiotic prescribing
- antimicrobial stewardship
- infection control
- novel antibiotics
- drug-resistant pathogens
- low- and middle-income countries
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Reza, N., Dubey, V., Sharland, M., & Hope, W. W. (2025). Antimicrobial use and resistance. BMJ, 391, e082681. https://doi.org/10.1136/bmj-2024-082681
How many times has this paper been cited?
48 times, according to OpenAlex on 17 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at BMJ: sign in and open the PDF from this page.
Who wrote this paper?
Nada Reza, Vineet Dubey, Mike Sharland, William W. Hope.
What is the DOI of this paper?
10.1136/bmj-2024-082681, permanently at https://doi.org/10.1136/bmj-2024-082681. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 17 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.